CURRENT OPTIMUM MANAGEMENT OF ANAPLASTIC GERM-CELL TUMORS OF THE TESTIS AND OTHER SITES

被引：61

作者：

NEWLANDS, ES ^{[1
]}

BAGSHAWE, KD ^{[1
]}

BEGENT, RHJ ^{[1
]}

RUSTIN, GJS ^{[1
]}

CRAWFORD, SM ^{[1
]}

HOLDEN, L ^{[1
]}

机构：

[1] CHARING CROSS & WESTMINSTER MED SCH,DEPT MED ONCOL,LONDON,ENGLAND

来源：

BRITISH JOURNAL OF UROLOGY | 1986年 / 58卷 / 03期

关键词：

D O I：

10.1111/j.1464-410X.1986.tb09061.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：307 / 314

页数：8

相关论文

共 31 条

[1] BAGSHAWE KD, 1983, CLIN ONCOLOGY, V2, P159
[2] THE TREATMENT OF ADVANCED TESTICULAR-CARCINOMA WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS MARROW SUPPORT
BLIJHAM, G
SPITZER, G
LITAM, J
ZANDER, AR
VERMA, DS
VELLEKOOP, L
SAMUELS, ML
MCCREDIE, KB
DICKE, KA
[J]. EUROPEAN JOURNAL OF CANCER, 1981, 17 (04) : 433 - 441
[3] PROBLEMS OF INTERPRETATION OF SERUM CONCENTRATIONS OF ALPHA-FETOPROTEIN (AFP) IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY FOR MALIGNANT GERM-CELL TUMORS
COPPACK, S
NEWLANDS, ES
DENT, J
MITCHELL, H
GOKA, G
BAGSHAWE, KD
[J]. BRITISH JOURNAL OF CANCER, 1983, 48 (03) : 335 - 340
[4] DAVIES JM, 1981, LANCET, V1, P928
[5] DEPUE RH, 1983, J NATL CANCER I, V71, P1151
[6] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER
EINHORN, LH
DONOHUE, J
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) : 293 - 298
[7] TUMOR-MARKER LEVELS AND PROGNOSIS IN MALIGNANT TERATOMA OF THE TESTIS
GERMALLUCH, JR
BEGENT, RHJ
BAGSHAWE, KD
[J]. BRITISH JOURNAL OF CANCER, 1980, 42 (06) : 850 - 855
[8] LEE E T, 1972, Computer Programs in Biomedicine, V2, P315, DOI 10.1016/0010-468X(72)90019-0
[9] IMPROVED SURVIVAL WITH CYCLIC CHEMOTHERAPY FOR NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
LOGOTHETIS, CJ
SAMUELS, ML
SELIG, D
SWANSON, D
JOHNSON, DE
VONESCHENBACH, AC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) : 326 - 335
[10] MACAULEY VM, 1982, CANCER CHEMOTHERAPY, V4, P179

← 1 2 3 4 →